Paediatric Vaccines for Travel Outside Europe-Reference-Cited by-同舟云学术

Paediatric Vaccines for Travel Outside Europe

Published:2021 Issue: Volume: Page:261-279
ISSN:
Container-title:Pediatric Vaccines and Vaccinations
language:
Short-container-title:

Author:

Prevatt Natalie,Behrens Ron H.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-030-77173-7_23

Reference28 articles.

1. Bhutta Z, et al. Immunogenicity and safety of the vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials. Lancet Infect Dis. 2014;14(2):119–29.

2. Biswal S, Borja-Tabora C, Martinez Vargas L, Velásquez H, Theresa Alera M, Sierra V, Johana Rodriguez-Arenales E, Yu D, Wickramasinghe VP, Duarte Moreira E Jr., Fernando AD, Gunasekera D, Kosalaraksa P, Espinoza F, López-Medina E, Bravo L, Tuboi S, Hutagalung Y, Garbes P, Escudero I, Rauscher M, Bizjajeva S, LeFevre I, Borkowski A, Saez-Llorens X, Wallace D; TIDES study group. Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial. Lancet. 2020 May 2;395(10234):1423–1433. doi: https://doi.org/10.1016/S0140-6736(20)30414-1. Epub 2020 Mar 17. Erratum in: Lancet. 2020 Apr 4;395(10230):1114.

3. Casey, M., Harris, J.B., Hyde, T.B. et al. Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak — Final Report Rebecca N Engl J Med 2019; 381:444–454.

4. CDC. Grading of recommendations, assessment, development, and evaluation (GRADE) for yellow fever vaccine booster doses. Advisory Committee on Immunization Practices. CDC. 2015.

5. de Menezes MR, Fernandes Leal Mda L, Homma A. Serious adverse events associated with yellow fever vaccine. Hum Vaccin Immunother. 2015;11(9):2183–7.